Patent · US Active

Substituted nucleosides, nucleotides and analogs thereof

US10487104B2 · kind B2 · utility

4Cited by

46References

20Claims

0Family size

Assignee

Janssen BioPharma, Inc. · US

Inventors

Leonid Beigelman · San Mateo, US
Guangyi Wang · Carlsbad, US
David Bernard Smith · San Mateo, US

Key dates

Filing date	Oct 16, 2018
Grant date	Nov 26, 2019
Priority date	—
Expiry date	Oct 16, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/213
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.